meta_pixel
Tapesearch Logo
Log in
This Week in Cardiology

Apr 19 2024 This Week in Cardiology

This Week in Cardiology

Medscape Podcasts

Medicine, Science, Health & Fitness

4.9963 Ratings

🗓️ 19 April 2024

⏱️ 29 minutes

🧾️ Download transcript

Summary

ACC Part 2: The TACT2 trial of chelation, inter-atrial shunts for HF, and triglyceride lowering; plus diltiazem and Factor Xa anticoagulants are the topics John Mandrola, MD, covers this week.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I. TACT 2

Chelation Therapy Provides No Benefit Post-MI

https://www.medscape.com/viewarticle/chelation-therapy-provides-no-benefit-post-mi-2024a10006l5

Chelation Therapy and CV Risk: Why TACT2 Showed No Benefit https://www.medscape.com/viewarticle/chelation-therapy-and-cv-risk-why-tact2-showed-no-benefit-2024a1000761?src=

  • JAMA TACT 1 paper https://jamanetwork.com/journals/jama/fullarticle/1672238
  • Diabetes Subgroup paper https://pubmed.ncbi.nlm.nih.gov/24254885/
  • A New Look at P-values https://evidence.nejm.org/doi/abs/10.1056/EVIDoa2300003
  • PARAGON HF https://www.nejm.org/doi/full/10.1056/NEJMoa1908655

II. Interatrial Shunts for HF

No Net HF Benefit for Interarterial Shunt Device

https://www.medscape.com/viewarticle/no-net-hf-benefit-interarterial-shunt-device-2024a10006kk

  • REDUCE LAP HF II https://doi.org/10.1016/S0140-6736(22)00016-2

III. Triglyceride Lowering

Early Olezarsen Results Show 50% Reduction in Triglycerides

https://www.medscape.com/viewarticle/early-olezarsen-results-show-50-reduction-triglycerides-2024a10006oz

Is It Time to Stop Treating High Triglycerides?

https://www.medscape.com/viewarticle/990126

  • NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2402309

Substantial Triglyceride Reduction With Plozasiran

https://www.medscape.com/viewarticle/substantial-triglyceride-reduction-plozasiran-2024a10006wf?icd=login_success_email_match_norm

  • JAMA Cardiology https://jamanetwork.com/journals/jamacardiology/article-abstract/2817469

IV. Diltiazem and Factor Xa inhibitors

  • JAMA Vanderbilt University Paper https://jamanetwork.com/journals/jama/fullarticle/2817546

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Transcript

Click on a timestamp to play from that location

0:00.0

You're listening to this week in cardiology from the heart

0:03.4

org medscape cardiology this podcast is intended for health care

0:07.6

professionals only any views expressed are the presenters own and do not

0:11.2

necessarily reflect the views of WebMD or Medscape.

0:15.1

You can now access the latest in medical news on your Amazon Alexa-enabled device.

0:19.7

Join me, Perry Wilson, every weekday morning for Medscape Medical Minute where I highlight the top

0:24.7

medical stories of the day.

0:26.5

To add Medscape Medical Minute to your flash briefing, search for Medscape Medical

0:30.1

Minute on Amazon and click enable or open the Amazon Alexa app go to skills

0:34.7

search for Medscape Medical Minute and click enable then say Alexa what's the

0:40.1

news or Alexa what's my flash briefing I hope you'll join us.

0:44.0

Hi everyone this is John Mandrola from the Heart

0:47.6

org medscape cardiology and this is this week in

0:51.2

cardiology for April 19th, 2024.

0:55.0

This week I'll do a second ACC recap.

0:59.0

We'll do the TAC-2 trial of Kealation Therapy. We'll do Relieve H.F. which is

1:05.8

interatrial shuns for heart failure. We'll do a couple of triglyceride lowering

1:10.8

trials and an interesting trial on Diltayasam Infactor 10A anticoaguments.

1:17.0

First, TAC2.

1:20.0

Let's start with a trial that teaches a vital lesson in critical appraisal and scientific skepticism.

1:27.0

I lead with this trial for an important reason.

1:30.0

Tectu studied pulation of heavy metals as a treatment for atherosclerotic vascular disease in patients who had diabetes.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.